ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 306107 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 306107; 2) Community: the network communities that were significantly associated with the response to NSC 306107; 3) Molecule: the relationships between components within communities and NSC 306107; 4) MDR: the compounds that were significantly associated with the NSC 306107.

NSC Compound Enrichment Correlation
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.035202825328704 -0.2704612
NSC 2039 Bioquin 0.035202825328704 0.042381558
NSC 266046 Oxaliplatin 0.035202825328704 -0.069346899
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.035202825328704 -0.22850563
NSC 337857 Null 0.0352028253287042 -0.059198197
NSC 357114 CS-12350 0.0352028253287042 0.24527406
NSC 365798 Fostamatinib disodium, Tamatinib fosdium 0.0352028253287042 -0.20916183
NSC 367480 Null 0.0352028253287042 -0.087817018
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0352028253287042 0.030103027
NSC 56410 Porfiromycin 0.0352028253287042 0.15313504
Total:120  Current:87    [First] [Prev] [Next] [Last]